• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number 42055150-120
Device Problem Material Separation (1562)
Patient Problem Foreign Body In Patient (2687)
Event Date 06/10/2022
Event Type  Injury  
Manufacturer Narrative
The device will be returned for analysis.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was to treat a right superficial femoral artery.A 5.5x150mm supera device was advanced to the lesion and deployed without issue.The delivery system was removed outside of the patient when it was noted that the white taper tip was not present on the device as it was removed off the guide wire.Fluoroscopy demonstrated that the tip was still on the guide wire, but at the end of the 6fr sheath.A snare device was used to successfully remove the broken tip.A clinically significant delay was reported as intervention was performed to remove the broken tip.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.The investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that during removal interaction with the 6fr sheath resulted in the reported tip separation.The treatment(s) appears to be related to the operational context of the procedure as a snare device was used to successfully remove the broken tip.A clinically significant delay was reported as intervention was performed to remove the broken tip.There is no indication of a product quality issue with respect to manufacture, design or labeling.D9, h3: device status changed from yes to no.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key14863490
MDR Text Key295021081
Report Number2024168-2022-07061
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2024
Device Catalogue Number42055150-120
Device Lot Number2020161
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/12/2022
Initial Date FDA Received06/29/2022
Supplement Dates Manufacturer Received07/22/2022
Supplement Dates FDA Received07/27/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/01/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-